{
  "pmcid": "11879325",
  "sha256": "636baed8a6fc99f34100612fbf0cd89cbd6ed1bc8231fcffc322467bdfb3479c",
  "timestamp_utc": "2025-11-09T23:21:57.503922+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 10.205596946564889,
    "reading_ease": 40.5596320610687,
    "word_count": 262
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Suture UMbilical MEsh Repair (SUMMER) Trial: A Randomised Controlled Trial"
      },
      "Trial_Design": {
        "score": 2,
        "evidence": "A randomised, controlled, parallel-group, double-blind, multicentre trial was conducted across six Swedish surgical units."
      },
      "Participants": {
        "score": 2,
        "evidence": "Adults with primary elective UHs ≤2 cm were eligible."
      },
      "Intervention": {
        "score": 2,
        "evidence": "Participants were randomised 1:1 to either 4 × 4 cm macroporous lightweight onlay mesh repair or conventional suture repair."
      },
      "Objective": {
        "score": 1,
        "evidence": "This trial evaluates surgical-site occurrences (SSOs) in suture versus mesh repair for umbilical hernias (UHs) ≤2 cm."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome is recurrence at 3 years, with secondary outcomes including SSOs and pain intensity at 30 days."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Intraoperative web-based randomisation ensured allocation concealment."
      },
      "Blinding": {
        "score": 2,
        "evidence": "Blinding included patients and outcome assessors."
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "From February 2020 to January 2024, 290 participants were randomised: 146 to suture repair and 144 to mesh repair."
      },
      "Number_Analysed": {
        "score": 2,
        "evidence": "After exclusions, 144 suture and 135 mesh participants were analysed."
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "SSOs (Clavien–Dindo grade ≥I) affected 32 mesh (23.7%) and 26 suture (18.1%) participants, with no significant increase for mesh (OR 1.39, 95% CI 0.78 to 2.51)."
      },
      "Harms": {
        "score": 1,
        "evidence": "Adverse events were similar between groups, with no severe complications reported."
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "Trial registration: NCT04231071."
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: Not specified."
      }
    },
    "total_score": 23,
    "max_score": 25
  }
}